October 24, 2018 09:40 AM EDTUpdated October 29, 04:41 AM

Hong Kong IPO delivers $421M to Innovent as another one of China's biotech unicorns hauls in big money

Say what you may about the biotech chapter of the Hong Kong Stock Exchange, but it has not stopped Innovent Biologics from reaping $421 million …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Hong Kong IPO de­liv­ers $421M to In­novent as an­oth­er one of Chi­na's biotech uni­corns hauls in big mon­ey